CorneaGen
Seattle
About CorneaGen
CorneaGen innovates cornea care, from new medical devices and biologics to therapeutics and interventions. CorneaGen is a mission-driven company committed to transforming how corneal surgeons treat and care for the cornea. CorneaGen supports corneal surgeons and their patients with a spectrum of services, including the latest in innovative products, delivery of the highest quality tissue, surgeon education, and advocacy for patient access and reimbursement policies.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 101 – 250
- Estimated revenue: $10K – $50K
- Total funding: $77.0M
- Funding stage: Early Stage Venture
- Last round: Series B (Jul 2019)
- Website: corneagen.com
- Phone: +1 (206) 701-5840
Industries & Categories
Biotechnology, Health Care, Health Diagnostics, Innovation Management, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/corneagen-4881 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.